Vermont Center fo Cancer Medicines & Blood Disorders
Vermont Center fo Cancer Medicines & Blood Disorders
endcapYour VisitmiddleYour TeammiddleNewly DiagnosedmiddleTypes of CancermiddleCancer TreatmentmiddleTestingmiddleCancer NewsmiddleClinical TrialsmiddleSupport & Resourcesendcap
Welcome Our Mission Appointments Emergencies & Phone Calls Insurance & Billing Locations Prescription Refills Patient Bill of Rights Privacy Policy Website Information
Johannes C. Nunnink, M.D. Dennis A. Sanders, M.D. Christian A. Thomas, M.D. Paul S. Unger, M.D. Christine Suratt, ANP
What is Cancer? Diagnosing Cancer Introduction to Cancer Treatment Optimizing Treatment Questions to Ask A Word about Clinical Trials Getting a Second Opinion
General Cancer Information Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Cervical Cancer Colon Cancer Esophageal Cancer Gastric Cancer Head & Neck Cancer Hodgkin's Lymphoma Leukemia Lung Cancer Melanoma Multiple Myeloma
More...
Non-Hodgkin's Lymphoma Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer Sarcoma Uterine Cancer Skin Cancer Testicular Cancer Thyroid Cancer
Treatment Overview Chemotherapy Radiation Therapy Surgery Hormonal Therapy Targeted Therapy Stem Cell Transplantation Side Effects of Treatment Complementary & Alternative
Overview Screening Tools Diagnostic & Monitoring Tests
Latest Cancer News Anal Cancer Bladder Cancer Bone Cancer Brain & CNS Breast Cancer Cervical Cancer Colon Cancer Complementary Alternative Medicine Esophageal Cancer Gastric Cancer Gene Therapy Head & Neck Cancer HIV Related Cancers Hodgkin's Lymphoma
More...
Liver Cancer Lung Cancer - Non-Small Cell Lung Cancer - Small Cell Malignant Mesothelioma Melanoma Multiple Myeloma Myelodysplastic Syndromes Neuroblastoma Non-Hodgkin's Lymphoma Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer Retinoblastoma
More...
Screening & Prevention Skin Cancer Stem Cell Transplant Supportive Care Testicular Cancer Thyroid Cancer Uterine Cancer Vaginal Cancer
Introduction What Are Clinical Trials? Phases of Clinical Trials How Are Clinical Trials Conducted? Clinical Trials Safeguards Participating in Clinical Trials The Cost of Clinical Trials Finding Specific Clinical Trials The Future of Clinical Trials Clinical Trials Database
Overview Caregivers Healing Environments Support Groups Journaling Birth Control and Sexuality Home Health Financial & Insurance Issues Advanced Directives Inspiration Movement & Exercise Life after Treatment Online Resources
floatmenu_left Home Home   Drug Dictionary Drug Dictionary   Cancer Dictionary Cancer Dictionary   Links Links   Contact Us Contact Us floatmenu_right
Vermont Center fo Cancer Medicines & Blood Disorders
E-mail this page   Print this page
Section Title

Non-Hodgkin's Lymphoma

Overview

Cancers that begin in cells of the lymph system are referred to as malignant lymphomas. The lymph system includes the spleen, thymus, tonsils, bone marrow, lymph nodes and circulating white blood cells called lymphocytes. Lymphocytes and the lymph system are part of the immune system that protects the body from disease and infection. Cancers of the lymph system are referred to as Hodgkin’s lymphoma or non-Hodgkin’s lymphoma.

Understanding treatment of lymphoma is fairly complicated because patients must know the correct histologic diagnosis and the stage of their lymphoma. Histologic classification of non-Hodgkin's lymphomas has undergone considerable changes that can lead to confusion for patients and doctors. In order to learn about treatment options, patients need to know the answers to the following questions:

  • Is the lymphoma classified as Hodgkin's or non-Hodgkin's lymphoma?
  • If it is non-Hodgkin's lymphoma, what kind (histologic type) of non-Hodgkin's lymphoma is it?
  • What is the stage or extent of spread of the lymphoma?

In order to understand the best treatment options available for lymphoma, it is important to determine the stage or where the cancer has spread in the body. All new treatment information is categorized and discussed by the stage, or extent, of the disease. Determining the extent of spread or the stage of the cancer requires a number of procedures including computerized tomography (CT) and/or Magnetic resonance imaging (MRI) scans and blood tests. The goal of staging lymphoma is to determine which patients have early and which have advanced stage cancer.

Stage I: Cancer is found only in a single lymph node, in the area immediately surrounding that node, or in a single organ.

Stage II: Cancer involves more than one lymph node area on one side of the diaphragm (the breathing muscle separating the abdomen from the chest).

Stage III: The cancer involves lymph node regions above and below the diaphragm. For example, there may be swollen lymph nodes under the arm and in the abdomen.

Stage IV: Cancer involves one or more organs outside the lymph system or a single organ and a distant lymph node site.

In some patients, the lymphoma may grow out of the lymph system into adjacent organs. This is referred to as extranodal extension and designated by an "E" following the stage. For example, a stage II lymphoma that extended into the lungs would be referred to as stage IIE.

Patients with malignant lymphoma may also experience general symptoms from their disease. Patients with fever, night sweats or significant weight loss are said to have "B" symptoms. If these specific symptoms are not present, patients are further classified as "A".

Relapsed/Refractory: The cancer has persisted or returned (recurred/relapsed) following treatment.